Showing results (2301-2310 of 2,907) with videos related to

Sort By:
Pageof 291
NPJ Parkinson'S Disease|January 11, 2022
Functional connectivity in Parkinson's disease candidates for deep brain stimulationLuigi Albano, Federica Agosta, Silvia Basaia, et al.
International Journal of Pharmaceutics|May 15, 2017
Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusionIsabel Lozoya-Agullo, Moran Zur, Noa Fine-Shamir, et al.
British Journal of Haematology|May 18, 2006
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, David J Inwards, et al.
Cancer|December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanomaRavi D Rao, Shernan G Holtan, James N Ingle, et al.
Neurology|February 1, 2013
Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsyChristopher M DeGiorgio, Jason Soss, Ian A Cook, et al.
Journal of Clinical Immunology|October 12, 2012
Treatment with low doses of polyclonal immunoglobulin improves B cell function during immune reconstitution in a murine modelAna Barahona Afonso, Lígia Neves Justo, Ana Cristina Queirós, et al.
Neurology and Therapy|January 11, 2024
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary PerspectivesMark S Freedman, Patricia K Coyle, Kerstin Hellwig, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Doppler Indices of the Uterine, Umbilical and Fetal Middle Cerebral Artery in Diabetic versus Non-Diabetic Pregnancy: Systematic Review and Meta-AnalysisSonja Perkovic-Kepeci, Andja Cirkovic, Natasa Milic, et al.
Frontiers in Immunology|July 3, 2026
Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approachesJacqueline A Turner, Marc D'Antonio, Heather N Montane, et al.
Melanoma Research|June 24, 2011
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccineMatthew S Block, Vera J Suman, Wendy K Nevala, et al.
Pageof 291